Complement‑targeted therapeutics continue to expand, with C3, C5, and alternative‑pathway inhibitors advancing through clinical pipelines. Creative Biolabs’ complement assay kit suite spans the ...

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

TSP-1 reduced C3 and C5 cleavage and formation of the membrane attack complex, attenuating complement-mediated injury in AAV models. Complement activation is a relevant driver in the pathomechanisms ...

(MENAFN- EIN Presswire) EINPresswire/ -- Creative Biolabs has expanded its portfolio of primary cell systems and functional assay tools, expanding its selection of primary macrophage preparations, ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES ...